Raymond James Financial
MEDP icon

Raymond James Financial’s Medpace MEDP Stock Holding History

Raymond James Financial’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.2M Buy
131,373
+42,079
+47% +$21.5M 0.02% 742
2025
Q4 		$50.2M Sell
89,294
-15,893
-15% -$9.02M 0.02% 817
2025
Q3 		$54.1M Sell
105,187
-16,073
-13% -$7.02M 0.02% 765
2025
Q2 		$38.1M Sell
121,260
-105,940
-47% -$31.8M 0.01% 933
2025
Q1 		$69.2M Sell
227,200
-8,011
-3% -$2.69M 0.03% 567
2024
Q4 		$78.1M Buy
+235,211
New +$79.8M 0.03% 512

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Raymond James Financial's MEDP Position: Q1 2026 in Review

Raymond James Financial increased its Medpace (MEDP) stake by 47% in Q1 2026, buying an estimated $21.5M and bringing the position to 131,373 shares worth $62.2M. The position accounts for 0.02% of the portfolio, ranked #742.

Raymond James Financial first reported a position in MEDP in Q4 2024 and has held it in 6 quarters since. The position peaked at $78.1M in Q4 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Raymond James Financial held 131,373 shares of Medpace worth $62.2M as of Q1 2026.
  • Raymond James Financial bought 42,079 Medpace shares in Q1 2026, an estimated $21.5M.
  • Medpace made up 0.02% of Raymond James Financial's portfolio in Q1 2026, its #742 holding.
  • Raymond James Financial first reported a position in Medpace in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Medpace position peaked at $78.1M in Q4 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.